Clinical Trials Directory

Trials / Completed

CompletedNCT05992701

Effectiveness and Safety of Directional Deep Brain Stimulation for Parkinson's Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Beijing Pins Medical Co., Ltd · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the PINS Deep Brain Stimulation (DBS) system, including the G107R/G107 IPG, L305/L306 directional leads, E204 extensions and related system components.

Detailed description

This is a prospective, open label, non-randomized study. The study will evaluate the clinical outcome and possible adverse effects of the directional DBS treatment. The following data will be collected: therapeutic window, Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating (MDS-UPDRS) Part III scores, Parkinson's Disease Questionnaire (PDQ-39) summary scores, total electrical energy delivered, the dosage of anti-parkinsonian medications, on time(h/d) without troublesome dyskinesia, and adverse events.

Conditions

Interventions

TypeNameDescription
DEVICEDirectional deep brain stimualtionDirectional deep brain stimualtion in the treatment of Parkinson's disease using L305/L306 leads and G107R/G107 implanted pulse generators (Beijing Pins Medical Co.).

Timeline

Start date
2021-07-28
Primary completion
2023-11-13
Completion
2023-12-23
First posted
2023-08-15
Last updated
2025-12-10

Locations

9 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05992701. Inclusion in this directory is not an endorsement.